Stocks
Organon & Co.OGN
NYSEHealthcarePharmaceuticals$6.35+0.32%
A global pharmaceutical company focused on women’s health, biosimilars, and a portfolio of established medicines that were largely spun out of Merck in 2021. Its products include contraception, fertility treatments, and legacy cardiovascular and respiratory drugs that generate steady cash flow acros...
Market Cap: $1.7B52W Range: $6.18 – $15.88
Congressional Interest in Organon & Co. (OGN)
4 members of Congress have disclosed 13 trades in Organon & Co. (OGN), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 8 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
13
Unique Politicians
4
Buys
5
Sells
8
Who in Congress Is Trading OGN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-08-26 | Rohit Khanna | buy | $1K – $15K |
| 2023-12-04 | Rohit Khanna | buy | $1K – $15K |